EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 43 / No 3 (September 2011) J Extra Corpor Technol, 43 3 (2011) 130-136 References
Free Access
Issue
J Extra Corpor Technol
Volume 43, Number 3, September 2011
Page(s) 130 - 136
DOI https://doi.org/10.1051/ject/201143130
Published online 15 September 2011
  1. Petrucci O, Vieira RW, do Carmo MR, Martins de Oliveira PP, Antunes N, Braile DM. Use of (all-blood) miniplegia versus crystalloid cardioplegia in an experimental model of acute myocardial ischemia. J Card Surg. 2008;23:361–5. [CrossRef] [Google Scholar]
  2. Martins AS, Silva MA, Padovani CR, Matsubara BB, Braile DM, Cataneo AJ. Myocardial protection by continuous, blood, antegraderetrograde cardioplegia in rabbits. Acta Cir Bras. 2007;22:43–6. [CrossRef] [PubMed] [Google Scholar]
  3. Krohn E, Stinner B, Flechenstein M, Gebhard MM, Bretschneider HJ. The cardioplegic solution HTK: Effects on membrane potential, intracellular K+ and Na+ activities in sheep cardiac Purkinje fibres. Pflugers Arch. 1989;415:269–75. [CrossRef] [PubMed] [Google Scholar]
  4. Argüero-Sánchez R, Mansilla-Olivares A, M-Rosales ML. Structural findings during myocardial preservation with HTK solution. Cir Cir. 2004;72:31–5. [Google Scholar]
  5. Dyszkiewicz W, Minten J, Flameng W. Long-term preservation of donor hearts: The effect of intra-and extracellular-type of cardioplegic solution on myocardial high-energy phosphate content. Mater Med Pol. 1990;75:147–51. [Google Scholar]
  6. Gebhard MM, Preusse CJ, Schnabel PA, Bretschneider HJ. Different effects of cardioplegic solution HTK during single or intermittent administration. Thorac Cardiovasc Surg. 1984;32:271–6. [CrossRef] [PubMed] [Google Scholar]
  7. Katayama O, Amrani M, Ledingham S, et al. Effect of cardioplegia infusion pressure on coronary artery endothelium and cardiac mechanical function. Eur J Cardiothorac Surg. 1997;11:751–62. [CrossRef] [Google Scholar]
  8. Adam H. ATP, ADP, AMP. In: Bergmeyer H, ed. Methods of Enzymatic Analysis. New York, NY: Academic Press;1965:541–73. [Google Scholar]
  9. Stokes KY, Abdith HK, Nelly CJ, Redmond HP, Bouchier-Hayes DJ. Thermotolerance attenuates ischemia-reperfusion induced renal injury and increased expression of ICAM-1. Transplantation. 1996;62:1143–4. [CrossRef] [PubMed] [Google Scholar]
  10. Kevelaitis E, Nyborg NC, Menasché P. Coronary endothelial dysfunction of isolated hearts subjected to prolonged cold storage: Patterns and contributing factors. J Heart Lung Transplant. 1999;18:239–47. [CrossRef] [PubMed] [Google Scholar]
  11. Quillen JE, Sellke FW, Brooks LA, Harrison DG. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation. 1990;82:586–94. [CrossRef] [PubMed] [Google Scholar]
  12. Bremer YA, Salloum F, Ockaili R, Chou E, Moskowitz WB, Kukreja RC. Sildenafil citrate (Viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits. Pediatr Res. 2005;57:22–7. [CrossRef] [PubMed] [Google Scholar]
  13. Velez DA, Morris CD, Budde JM, et al. All-blood (miniplegia) versus dilute cardioplegia in experimental surgical revascularization of evolving infarction. Circulation. 2001;104(Suppl I):I296–302. [Google Scholar]
  14. McCann UG, Lutz CJ, Picone AL, et al. Whole blood cardioplegia (minicardioplegia) reduces myocardial edema after ischemic injury and cardiopulmonary bypass. J Extra Corpor Technol. 2006;38:14–21. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  15. Palatianos GM, Balentine G, Papadakis EG, et al. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg. 2004;77:956–61. [CrossRef] [Google Scholar]
  16. Summers ST, Wyatt LE, Freischlag JA. Persistent neutrophil (PMN) activation 24 hr after ischemia and reperfusion. J Surg Res. 1994;56:130–3. [CrossRef] [Google Scholar]
  17. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147:153–9. [CrossRef] [Google Scholar]
  18. Cooper JR, Giesecke NM. Hemodilution and priming solutions. In: Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, eds. Cardiopulmonary Bypass. Principles and Practice. 3rd ed. Philadelphia, PA: Wolters Kluwer;2008:411–22. [Google Scholar]
  19. Licker M, Ellenberger C, Sierra J, Kalangos A, Diaper J, Morel D. Cardioprotective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery. Chest. 2005;128:838–47. [CrossRef] [PubMed] [Google Scholar]
  20. Spiess BD, Ley C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. McSPI Research Group. J Thorac Cardiovasc Surg. 1998;116:460–7. [CrossRef] [Google Scholar]
  21. Toth Z, Gyorimolnar I, Abraham H, Hevesi A. Cannulation and cardiopulmonary bypass produce selective brain lesions in pigs. Asian Cardiovasc Thorac Ann. 2006;14:273–8. [CrossRef] [PubMed] [Google Scholar]
  22. Onorati F, De Feo M, Mastroroberto P, et al. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg. 2005;79:837–45. [CrossRef] [Google Scholar]
  23. Scholl FG, Drinkwater DC. Antegrade, retrograde, or both? In: Salerno TA, Ricci M, eds. Myocardial Protection. New York, NY: Blackwell Publishing;2004:82–7. [Google Scholar]
  24. Pevni D, Frolkis I, Shapira I, et al. Heparin added to cardioplegic solution inhibits tumor necrosis factor-α production and attenuates myocardial ischemic-reperfusion injury. Chest. 2005;128:1805–11. [CrossRef] [PubMed] [Google Scholar]
  25. Yeh CH, Wang YC, Wu YC, Chu JJ, Lin PJ. Continuous tepid blood cardioplegia can preserve coronary endothelium and amelio rate the occurrence of cardiomyocyte apoptosis. Chest. 2003;123:1647–54. [CrossRef] [PubMed] [Google Scholar]
  26. Ghazy T, Allham O, Ouda A, Kappert U, Matschke K. Is repeated administration of blood-cardioplegia really necessary? Interact Cardiovasc Thorac Surg. 2009;8:517–23. [CrossRef] [PubMed] [Google Scholar]
  27. Schroder C, Heintz A, Pexa A, Rauen U, Deussen A. Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives. Eur J Cardiothorac Surg. 2007;31:821–6. [CrossRef] [Google Scholar]
  28. Paraskevaidis IA, Iliodromitis EK, Vlahakos D, et al. Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid per-oxidation and protects the myocardium against reperfusion injury: Immediate and long-term significance. Eur Heart J. 2005;26:263–70. [CrossRef] [PubMed] [Google Scholar]
  29. Jacob S, Kallikourdis A, Sellke F, Dunning J. Is blood cardioplegia superior to crystalloid cardioplegia? Interact Cardiovasc Thorac Surg. 2008;7:491–8. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.